Skip to main content
Voltar para Discussões

A ascensão da China como inovadora global em farmacêutica (incentivos importam)

Healthcare
Global
Iniciado March 24, 2026

This paper examines China’s transition from pharmaceutical “free rider” to global innovator over the last decade. In 2010, China accounted for less than 8% of global clinical trials; by 2020, it had surpassed the US in annual registered clinical trial volume. To study this transformation, we compile a comprehensive, synchronized database spanning the pharmaceutical drug […] The post The rise of China as a global innovator in pharma (incentives matter) appeared first on Marginal REVOLUTION. Re...

Artigos de Fontes

Adicionar afirmação Análise 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
5 afirmações para votar • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 5/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Publicado por will • Mar 24, 2026
Embora o crescimento da China no setor farmacêutico seja notável, isso levanta preocupações sobre práticas éticas e supervisão regulatória no desenvolvimento de medicamentos.
Traduzido por IA · Ver original

While China's growth in the pharma sector is notable, it raises concerns about ethical practices and regulatory oversight in drug development.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discussão
Be first to respond
Vote to see results
CLAIM Publicado por will • Mar 24, 2026
O crescimento da China como inovadora farmacêutica é um desenvolvimento positivo, pois aumenta a competição global e reduz os preços dos medicamentos.
Traduzido por IA · Ver original

China's rise as a pharmaceutical innovator is a positive development, as it enhances global competition and drives down drug prices.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discussão
Be first to respond
Vote to see results
CLAIM Publicado por will • Mar 24, 2026
A mudança no volume de ensaios clínicos para a China reflete tendências mais amplas de globalização e deve ser vista como uma evolução natural na indústria farmacêutica.
Traduzido por IA · Ver original

The shift in clinical trial volume to China reflects broader trends in globalization and should be seen as a natural evolution in the pharma industry.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discussão
Be first to respond
Vote to see results
CLAIM Publicado por will • Mar 24, 2026
O avanço rápido da China em produtos farmacêuticos apresenta riscos de roubo de propriedade intelectual e prejudica os padrões globais estabelecidos em segurança de medicamentos.
Traduzido por IA · Ver original

China's rapid advancement in pharma poses risks of intellectual property theft and undermines established global standards in drug safety.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discussão
Be first to respond
Vote to see results
CLAIM Publicado por will • Mar 24, 2026
A transição da China para inovadora global em produtos farmacêuticos poderia levar a melhores resultados de saúde em todo o mundo, beneficiando populações em todos os lugares.
Traduzido por IA · Ver original

China's transition to a global innovator in pharmaceuticals could lead to better healthcare outcomes worldwide, benefiting populations everywhere.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discussão
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us